Table 3.
Secondary outcomes: Abstinence at the end of the programme, 14 days point prevalence and satisfaction with the programme for pregnant and non-pregnant women (given as the % of all pregnant or non-pregnant patients and responders only). The OR and 95% CI are shown.
| Women in GSP | Pregnant | Non-pregnant | |||||
|---|---|---|---|---|---|---|---|
| Effect (%) | Effect (%) | ||||||
| Characteristics (n) | All | Responders | Characteristics (n) | All | Responders | ||
| Patients | 1,006 | 735 | 9,676 | 7,252 | |||
| Smoke free at end of programme | 419 | 41.7% | 57.0% | 4,729 | 48.9% | 65.2% | |
| OR (95% CI) | 0.98 (0.78–1.21) | 1 | |||||
| Patients | 1,006 | 763 | 9,676 | 7,319 | |||
| Point prevalence (14 days) | 306 | 30.4% | 40.1% | 2,801 | 28.9% | 38.3% | |
| OR (95% CI) | 1.27 (1.05–1.54) * | 1 | |||||
| Patients | 1,006 | 742 | 9,676 | 7,170 | |||
| Satisfied with the programme | 600 | 59.6% | 80.9% | 5,853 | 60.5% | 81.6% | |
| OR (95% CI) | 1.00 (0.79–1.26) | 1 | |||||
* Significant. The results were considered significant if the CI did not include the value 1.